Saul Priceman, PhD, is an assistant professor in the T Cell Immunotherapy Program at City of Hope and a trained tumor immunologist with expertise in T cell biology and cancer immunotherapy. He is developing chimeric antigen receptor (CAR)-based T cell immunotherapy primarily for solid cancers, with a strong focus on metastatic disease in breast, prostate and pancreatic cancer.
Dr. Priceman will discuss and answer questions he hears from patients and others about Immuno-Oncology, an exciting new treatment approach being explored in prostate and other cancers.
Resources
Access to the archive recording of November 11 webinar recording – coming soon
PowerPoint for the November 12 webinar – coming soon